FFCP PHASE1:Mm9::chr9:110317999..110318003,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr9:110317999..110318003,+|id=chr9:110317999..110318003,+|ontology_enrichment_celltype=CL:0000355!1.10e-11!9|ontology_enrichment_celltype_v019_2=CL:0000355,1.26e-10,9|ontology_enrichment_disease=DOID:0060100!1.69e-33!3;DOID:4045!1.69e-33!3;DOID:0050686!3.63e-17!6|ontology_enrichment_disease_v019_2=DOID:0060100,1.54e-29,3;DOID:4045,1.54e-29,3;DOID:0050686,2.21e-15,6|ontology_enrichment_uberon=UBERON:0001134!1.10e-11!9;UBERON:0002036!1.10e-11!9;UBERON:0002385!1.10e-11!9;UBERON:0000486!1.10e-11!9;UBERON:0001015!1.10e-11!9;UBERON:0004290!1.10e-11!9;UBERON:0003082!1.10e-11!9;UBERON:0000383!1.39e-10!10;UBERON:0002329!1.11e-09!11;UBERON:0003077!1.11e-09!11;UBERON:0003059!1.11e-09!11;UBERON:0007282!1.11e-09!11;UBERON:0009618!1.11e-09!11;UBERON:0007285!1.11e-09!11|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.26e-10,9;UBERON:0002036,1.26e-10,9;UBERON:0002385,1.26e-10,9;UBERON:0000486,1.26e-10,9;UBERON:0007503,1.26e-10,9;UBERON:0001015,1.26e-10,9;UBERON:0002329,1.26e-10,9;UBERON:0003082,1.26e-10,9;UBERON:0003059,1.26e-10,9;UBERON:0007282,1.26e-10,9;UBERON:0004290,1.26e-10,9;UBERON:0009618,1.26e-10,9;UBERON:0000383,1.14e-09,10;UBERON:0007524,6.95e-09,11;UBERON:0003077,6.95e-09,11;UBERON:0007285,6.95e-09,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.51118978442145,0.7813353445238,1.57057123192139,7.05877785637217,6.83045484958446,0.485510353031154,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.124406970610093,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.185194527369712,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr9:110317999..110318003,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr9:110317999..110318003,+ | |||
|description=CAGE_peak_at_chr9:110317999..110318003,+ | |||
|id=chr9:110317999..110318003,+ | |||
|ontology_enrichment_celltype=CL:0000355!1.10e-11!9 | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,1.26e-10,9 | |||
|ontology_enrichment_disease=DOID:0060100!1.69e-33!3;DOID:4045!1.69e-33!3;DOID:0050686!3.63e-17!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,1.54e-29,3;DOID:4045,1.54e-29,3;DOID:0050686,2.21e-15,6 | |||
|ontology_enrichment_uberon=UBERON:0001134!1.10e-11!9;UBERON:0002036!1.10e-11!9;UBERON:0002385!1.10e-11!9;UBERON:0000486!1.10e-11!9;UBERON:0001015!1.10e-11!9;UBERON:0004290!1.10e-11!9;UBERON:0003082!1.10e-11!9;UBERON:0000383!1.39e-10!10;UBERON:0002329!1.11e-09!11;UBERON:0003077!1.11e-09!11;UBERON:0003059!1.11e-09!11;UBERON:0007282!1.11e-09!11;UBERON:0009618!1.11e-09!11;UBERON:0007285!1.11e-09!11 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.26e-10,9;UBERON:0002036,1.26e-10,9;UBERON:0002385,1.26e-10,9;UBERON:0000486,1.26e-10,9;UBERON:0007503,1.26e-10,9;UBERON:0001015,1.26e-10,9;UBERON:0002329,1.26e-10,9;UBERON:0003082,1.26e-10,9;UBERON:0003059,1.26e-10,9;UBERON:0007282,1.26e-10,9;UBERON:0004290,1.26e-10,9;UBERON:0009618,1.26e-10,9;UBERON:0000383,1.14e-09,10;UBERON:0007524,6.95e-09,11;UBERON:0003077,6.95e-09,11;UBERON:0007285,6.95e-09,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.51118978442145,0.7813353445238,1.57057123192139,7.05877785637217,6.83045484958446,0.485510353031154,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.124406970610093,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.185194527369712,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr9:110317999..110318003,+ | |||
}} |
Latest revision as of 15:00, 4 August 2015
Short description: | p@chr9:110317999..110318003, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr9:110317999..110318003, + |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 1.26e-10 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 1.26e-10 | 9 |
striated muscle tissue | 1.26e-10 | 9 |
muscle tissue | 1.26e-10 | 9 |
multilaminar epithelium | 1.26e-10 | 9 |
epithelial vesicle | 1.26e-10 | 9 |
musculature | 1.26e-10 | 9 |
somite | 1.26e-10 | 9 |
myotome | 1.26e-10 | 9 |
presomitic mesoderm | 1.26e-10 | 9 |
presumptive segmental plate | 1.26e-10 | 9 |
dermomyotome | 1.26e-10 | 9 |
trunk paraxial mesoderm | 1.26e-10 | 9 |
musculature of body | 1.14e-09 | 10 |
dense mesenchyme tissue | 6.95e-09 | 11 |
paraxial mesoderm | 6.95e-09 | 11 |
presumptive paraxial mesoderm | 6.95e-09 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 1.54e-29 | 3 |
muscle cancer | 1.54e-29 | 3 |
organ system cancer | 2.21e-15 | 6 |